The impact of IL‐10 and IL‐17 on myeloid‐derived suppressor cells in vitro and in vivo in a murine model of asthma
European Journal of Immunology · 2024
DOI: 10.1002/eji.202350785 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, 2024. Verfasst von Charlotte Vetter und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Laboratory Medicine, member of the German Center for Lung Research (DZL), Universities of Giessen and Marburg Lung Center (UGMLC), Phili…. Hauptthemen laut MEDLINE: Asthma, Disease Models, Animal, Interleukin-10, Interleukin-17. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, German Center for Lung Disease, Foundation for Pathobiochemistry and Molecular Diagnostics.
Abstract (Originalsprache)
Myeloid‐derived suppressor cells (MDSCs) hold promise for clinical applications due to their immunosuppressive properties, particularly in the context of inflammation. In the present study, the number and immunosuppressive activity of MDSCs isolated from naïve Il10 −/− , Il17 −/− , and WT mice as control, as well as from house dust mite extract (HDM)‐induced asthmatic Il10 −/− and Il17 −/− mice, were investigated. IL‐10 deficiency increased the number of polymorphonuclear (PMN)‐MDSCs in the lung, spleen, and bone marrow, without concurrent impairment of their suppressive activity in vitro. In the asthma model, the IL‐17 knockout was concomitant with a lower number and activity of monocytic (M)‐MDSCs and an altered inflammatory reaction with impaired lung function. Additionally, we found a higher baseline inflammation of the Il17 −/− mice in the lung, manifested in increased airway resistance. We conclude that the impact of IL‐10 and IL‐17 deficiency on MDSCs differs in the context of inflammation. Accordingly, the in vitro experiments demonstrated an increased number of PMN‐MDSCs across tissues in Il10 −/− mice, which indicates that IL‐10 might serve a pivotal role in preserving immune homeostasis under physiological circumstances. In the context of HDM‐induced airway inflammation, IL‐17 was found to be an important player in the suppression of pulmonary inflammation and regulation of M‐MDSCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Laboratory Medicine, member of the German Center for Lung Research (DZL), Universities of Giessen and Marburg Lung Center (UGMLC), Philipps University Marburg, Marburg, Germany.
- Small Animal Imaging Core Facility, Center for Tumor Biology and Immunology (ZTI), Philipps University Marburg, Marburg, Germany.
ORCID-Profile: Chiel van Geffen
Förderung
- Deutsche Forschungsgemeinschaft
- German Center for Lung Disease
- Foundation for Pathobiochemistry and Molecular Diagnostics
- Stiftung für Pathobiochemie und Molekulare Diagnostik
Zitieren
APA
Vetter, C., Schieb, J., Vedder, N., Lange, T., Brunn, T., van Geffen, C., Gercke, P., & Kolahian, S. (2024). The impact of IL‐10 and IL‐17 on myeloid‐derived suppressor cells in vitro and in vivo in a murine model of asthma. European Journal of Immunology. https://doi.org/10.1002/eji.202350785
Vancouver
Vetter C, Schieb J, Vedder N, Lange T, Brunn T, van Geffen C, et al. The impact of IL‐10 and IL‐17 on myeloid‐derived suppressor cells in vitro and in vivo in a murine model of asthma. European Journal of Immunology. 2024. doi:10.1002/eji.202350785
BibTeX
@article{Vetter2024,
author = {Vetter, Charlotte and Schieb, Jakob and Vedder, Nora and Lange, Tim and Brunn, Tobias and van Geffen, Chiel and Gercke, Philipp and Kolahian, Saeed},
title = {The impact of IL‐10 and IL‐17 on myeloid‐derived suppressor cells in vitro and in vivo in a murine model of asthma},
journal = {European Journal of Immunology},
year = {2024},
doi = {10.1002/eji.202350785}
}
EUVIMED